The International Osteoporosis Foundation (IOF) has presented the prestigious IOF President’s Award to Professor Peter Ebeling AO. The Award honours individuals who have made a significant and longstanding contribution to the advancement of the work of the IOF, through furthering one or more of the mission statements and/or goals of the Foundation.

The Award was presented by IOF President Professor Nicholas Harvey at the Opening Session of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2024) in London, UK, on April 11th, 2024. Professor Harvey stated: "I am delighted to present this award to my esteemed colleague, whose numerous years of dedicated service have greatly enriched IOF's initiatives in research and education. Through his active participation in IOF's Board of Governance, Scientific Committee, and Regional Advisory Council for the Asia Pacific,  Peter Ebeling has made major contributions to the Foundation’s programs, outreach efforts, and impact within the scientific, policy and public spheres."

As an internationally renowned expert in the bone field, Professor Ebeling AO is Head of the Department of Medicine and Head of the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and health Sciences, Monash University, Melbourne, Australia. He has been an IOF Board member since 2012, and is an ex-officio member of the IOF Asia Pacific Regional Advisory Council. 

Professor Ebeling stated: “I have been privileged to contribute to IOF activities over the last 12 years and to have witnessed the continuing growth and global influence of the IOF over that time. I am deeply honoured to be the recipient of the 2024 IOF President’s Award and I look forward to continue to energetically serve and support the IOF to advance bone health globally and to help all of our patients lead better lives.”

About Professor Peter Ebeling AO FAHMS 
Professor Ebeling AO FAHMS is an endocrinologist and Head of the Department of Medicine, and Head of the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, in Melbourne, Victoria, Australia. He is a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS and in 2023, and was also elected a Fellow of the Royal College of Physicians (London). He was inaugural Director of the Australian Institute of Musculoskeletal Science. In 2015, Professor Ebeling was made an Officer of the General Division of the Order of Australia for distinguished services in the field of bone health. 

Research interests include: musculoskeletal health and diseases; public health aspects of vitamin D; post-transplantation osteoporosis; rare bone diseases and osteoporosis in men. Professor Ebeling was Associate Editor of JBMR®, Editor of Clinical Endocrinology (Oxf) and the inaugural Editor-in-Chief of both Bone Reports and JBMR® Plus. He currently serves as Editor-in-Chief of Bone (from January 2024) and on the Editorial Board of Osteoporosis International. He is a Past President of the American Society of Bone and Mineral Research, the first non-North American to serve in this international leadership role. He is also Chair of the Board for Healthy Bones Australia, member of the International Osteoporosis Foundation Board of Directors, an Executive Committee member of the Asia Pacific Consortium on Osteoporosis (APCO); a Past-President of the Endocrine Society of Australia, and a Past-President of Australian and New Zealand Bone and Mineral Society. Professor Ebeling served on the Australian National Health and Medical Research Council’s Research Committee from 2015-2018. He has a total of over 536 peer-reviewed publications with over 36,000 citations and a h-index of 93. For the last four years, he has been named Australia's top endocrinology researcher while Monash University has been the top Australian University for Endocrinology research (according to the Australian Newspaper research magazine). He also teaches and mentors medical students and supervises a number of research higher degree students in the Department of Medicine at Monash University, and advanced physician trainees in endocrinology at Monash Health, Victoria's largest health service.

###
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including osteoporosis, osteoarthritis, sarcopenia, and frailty. The WCO-IOF-ESCEO 2024 is being held from April 11-14, 2024 in London, UK. For complete information visit www.wco-iof-esceo.org/    

The next WCO-IOF-ESCO is planned from April 10-13, 2025 in Rome, Italy.  

About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than 330 patient, medical and research organizations, work together to make fracture prevention and healthy mobility a worldwide healthcare priority. www.osteoporosis.foundation  @iofbonehealth